HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

GENFLEET-B

31.540

+0.2800.90%

Volume:161.60K

Turnover:5.00M

Market Cap:11.67B

PE:-15.96

High:31.580

Open:30.900

Low:30.000

Close:31.260

52wk High:50.200

52wk Low:24.320

Shares:370.00M

HK Float Shares:338.00M

Volume Ratio:2.34

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.976

ROE:--

ROA:-30.27%

PB:-4.03

PE(LYR):-15.96

PS:55.05

Loading ...

Overview Company News Filings

Company Profile

Company Name:

GENFLEET-B

Exchange:

SEHK

Establishment Date:

2017

Employees:

94

Office Location:

Floors 2, 3, 4, and 5 Building 8,1206 Zhangjiang Road,Building A Pudong District,Pilot Free Trade Zone,Shanghai,China

Website:

http://www.genfleet.com

Zip Code:

201203

Phone:

86 21 6882 1388

Fax:

- -

Introduction:

GenFleet Therapeutics (Shanghai) Inc is a China-based company principally engaged in the development of innovative drugs. The Company provides effective new treatment solutions for tumors, autoimmune and inflammatory diseases, covering target discovery, molecular discovery and evaluation, translational science and clinical development, as well as key chemistry manufacturing and controls aspects including formulation research, process development and quality analysis. The Company is mainly engaged in the development of new molecular entities, novel molecular modalities, investigation of molecular process routes and quality standards, and exploration of differentiated clinical development strategies and paths. The Company mainly primarily operates in the domestic and international markets.

Directors

Name

Position

LV Qiang

Chairman of the Board,Executive Director,Chairman of the Nomination Committee

LAN Jiong

Executive Director,Member of the Remuneration and Assessment Committee

ZHANG Wei

Executive Director

Christine Lu Wong

Independent Director,Member of the Nomination Committee,Chairman of the Audit Committee

ZHOU De Min

Independent Director,Member of the Remuneration and Assessment Committee,Member of the Audit Committee

LI Bo

Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee

ZHU Jing Yang

Director,Member of the Audit Committee

TAO Sha

Director

XUE Meng Jun

Supervisory

LIN Chong Lan

Employee Supervisor

MA Rui

Employee Supervisor

Shareholders

Name

Position

LAN Jiong

CEO,General Manager

ZHANG Wei

Board Secretary,Corporate Secretary

WU Dong Cheng

Corporate Secretary

WANG Yu

Other Senior Executives

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/02595/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02595","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02595\",,,,,undefined,":{"symbol":"02595","market":"HK","secType":"STK","nameCN":"GENFLEET-B","latestPrice":31.54,"timestamp":1763085199043,"preClose":31.26,"halted":0,"volume":161600,"delay":0,"floatShares":338000000,"shares":370000000,"eps":-1.976,"marketStatus":"Trading","change":0.28,"latestTime":"11-14 09:53:35","open":30.9,"high":31.58,"low":30,"amount":5000188,"amplitude":0.050544,"askPrice":31.54,"askSize":200,"bidPrice":31.5,"bidSize":5200,"shortable":0,"etf":0,"ttmEps":-2.744,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1763092800000},"marketStatusCode":2,"adr":0,"listingDate":1758211200000,"exchange":"SEHK","adjPreClose":31.26,"openAndCloseTimeList":[[1763083800000,1763092800000],[1763096400000,1763107200000]],"volumeRatio":2.337646,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02595\",,,,,undefined,":{"symbol":"02595","floatShares":338000000,"roa":"-30.27%","roe":"--","lyrEps":-1.976,"volumeRatio":2.337646,"shares":370000000,"dividePrice":0,"high":31.58,"amplitude":0.050544,"preClose":31.26,"low":30,"week52Low":24.32,"pbRate":"-4.03","psRate":"55.05","week52High":50.2,"institutionHeld":0,"latestPrice":31.54,"committee":0.925926,"eps":-1.976,"divideRate":0,"volume":161600,"delay":0,"ttmEps":-2.744,"open":30.9,"prevYearClose":20.39,"prevWeekClose":27,"prevMonthClose":27.32,"prevQuarterClose":40,"fiveDayClose":27,"twentyDayClose":31.2,"sixtyDayClose":20.39},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02595\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02595\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02595\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02595\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02595","date":"2025-11-12","current":-11.392128,"percent":0.6,"low":-19.62221,"twenty":-18.638898,"median":-10.678396,"eighty":-9.900509,"high":-9.058573,"avg":-13.037433,"sd":3.917123,"marketCap":10718410272},"quantilePoints":[{"date":"2025-09-19","current":-19.62221,"twenty":-19.62221,"median":-19.62221,"eighty":-19.62221,"marketCap":14538840523},{"date":"2025-09-26","current":-17.850791,"twenty":-18.989349,"median":-18.569255,"eighty":-18.336187,"marketCap":13192012066},{"date":"2025-10-03","current":-19.06699,"twenty":-19.162092,"median":-18.845312,"eighty":-18.417026,"marketCap":14124431767},{"date":"2025-10-10","current":-11.809112,"twenty":-19.045684,"median":-18.645404,"eighty":-16.087956,"marketCap":11948785798},{"date":"2025-10-17","current":-10.861917,"twenty":-19.006201,"median":-18.336187,"eighty":-11.374297,"marketCap":10981832034},{"date":"2025-10-24","current":-9.567304,"twenty":-18.816504,"median":-12.899451,"eighty":-10.554523,"marketCap":9676444452},{"date":"2025-10-31","current":-9.989391,"twenty":-18.681528,"median":-11.762498,"eighty":-10.081819,"marketCap":10118416331},{"date":"2025-11-07","current":-9.878556,"twenty":-18.646705,"median":-10.725216,"eighty":-9.89625,"marketCap":9999899010},{"date":"2025-11-12","current":-10.588152,"twenty":-18.638898,"median":-10.678396,"eighty":-9.900509,"marketCap":10718410272}],"updateTime":1763070291788},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":593382755,"yearFounded":2017,"employeeNum":94,"address":"Floors 2, 3, 4, and 5 Building 8,1206 Zhangjiang Road,Building A Pudong District,Pilot Free Trade Zone,Shanghai,China","zipCode":"201203","officePhone":"86 21 6882 1388"},"stockCompanyDetail":{"websiteUrl":"http://www.genfleet.com","stockEarnings":[{"period":"1week","weight":0.1552},{"period":"1month","weight":0.0064},{"period":"3month","weight":0.5331},{"period":"ytd","weight":0.5331}],"compareEarnings":[{"period":"1week","weight":0.0222},{"period":"1month","weight":0.0641},{"period":"3month","weight":0.0713},{"period":"6month","weight":0.1597},{"period":"1year","weight":0.3657},{"period":"ytd","weight":0.3496}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"GenFleet Therapeutics (Shanghai) Inc is a China-based company principally engaged in the development of innovative drugs. The Company provides effective new treatment solutions for tumors, autoimmune and inflammatory diseases, covering target discovery, molecular discovery and evaluation, translational science and clinical development, as well as key chemistry manufacturing and controls aspects including formulation research, process development and quality analysis. The Company is mainly engaged in the development of new molecular entities, novel molecular modalities, investigation of molecular process routes and quality standards, and exploration of differentiated clinical development strategies and paths. The Company mainly primarily operates in the domestic and international markets.","exchange":"SEHK","name":"GENFLEET-B","nameEN":"GENFLEET-B"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"02595\",market:\"HK\",,,undefined,":{"directors":[{"name":"LV Qiang","position":"Chairman of the Board,Executive Director,Chairman of the Nomination Committee"},{"name":"LAN Jiong","position":"Executive Director,Member of the Remuneration and Assessment Committee"},{"name":"ZHANG Wei","position":"Executive Director"},{"name":"Christine Lu Wong","position":"Independent Director,Member of the Nomination Committee,Chairman of the Audit Committee"},{"name":"ZHOU De Min","position":"Independent Director,Member of the Remuneration and Assessment Committee,Member of the Audit Committee"},{"name":"LI Bo","position":"Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee"},{"name":"ZHU Jing Yang","position":"Director,Member of the Audit Committee"},{"name":"TAO Sha","position":"Director"},{"name":"XUE Meng Jun","position":"Supervisory"},{"name":"LIN Chong Lan","position":"Employee Supervisor"},{"name":"MA Rui","position":"Employee Supervisor"}],"executives":[{"name":"LAN Jiong","position":"CEO,General Manager"},{"name":"ZHANG Wei","position":"Board Secretary,Corporate Secretary"},{"name":"WU Dong Cheng","position":"Corporate Secretary"},{"name":"WANG Yu","position":"Other Senior Executives"}]}}}